Drug & Supplement Interactions

Diosmin + Darolutamide

Brand name of Darolutamide

  • Nubeqa

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated November 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Moderate Interaction

Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates. Of the 2 interaction records for this pair, the most serious is rated moderate.

This also applies to Nubeqa, a brand name of darolutamide.

Read the Full Interaction Report

Dr. Brian Staiger’s Quick Take

Diosmin may slow a liver enzyme that clears Nubeqa (darolutamide), so it could build up and bring more fatigue, achy joints or muscles, rash, or blood pressure changes. The evidence is mostly theoretical, but check with your oncologist or pharmacist before adding diosmin.

Read his full note1-minute read
Moderate
Possible
2
BOthers: D

Ask a Question About This Combination

Ask in your own words about taking Diosmin with Darolutamide. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Diosmin and Darolutamide Interaction

2 interaction records apply to these two. Each one is explained separately below.

Why Are There 2 Interaction Records?

We file Diosmin’s interactions under single medicines and under categories of medicines that share an effect. Darolutamide is named in, or belongs to, 2 of them, so 2 records apply. They can describe the same effect, so they are not 2 separate risks. We’ve listed each one below; the most serious of them (Moderate) sets the overall rating.

Moderate Interaction 1 of 2

Diosmin With Cytochrome P450 3A4 (CYP3A4) Substrates

Why this applies to Darolutamide

  1. The SupplementDiosmin
  2. Interacts With the CategoryCytochrome P450 3A4 (CYP3A4) Substrates
  3. Which IncludesDarolutamide

We sort drugs into categories. Darolutamide is in our Cytochrome P450 3A4 (CYP3A4) Substrates category, and Diosmin interacts with every drug in it, so this interaction applies to Darolutamide.

Interaction Details Explained

Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates.
Laboratory research is conflicting with respect to the effects of diosmin on CYP3A4. Some research suggests that diosmin does not affect CYP3A4 activity. However, other research suggests that diosmin alters the metabolism of carbamazepine, a CYP3A4 substrate. Laboratory and animal research show that oral administration of diosmin for 7 days prior to oral administration of carbamazepine increases plasma concentrations of carbamazepine, decreases the clearance of carbamazepine, and decreases the formation of carbamazepine's active metabolite. Additionally, pharmacokinetic research in healthy male subjects shows that taking diosmin (Venex) 500 mg daily for 10 days prior to oral administration of carbamazepine 200 mg increases blood levels of carbamazepine by approximately 58% and decreases carbamazepine clearance by 42%. It is speculated that diosmin reduces the metabolism of carbamazepine by inhibiting CYP3A4. Diosmetin, a metabolite of diosmin, may also inhibit CYP3A4.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade BBased on a study in people that did not assign them at random.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Diosmin + Cytochrome P450 3A4 (CYP3A4) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the gist: your prostate cancer medication Nubeqa (darolutamide) is cleared from your body partly by a liver enzyme called CYP3A4. Diosmin may slow that same enzyme down. If it does, darolutamide could build up a bit higher than usual, which can mean more of its typical side effects, things like fatigue, achy joints or muscles, rash, or changes in blood pressure.

I'll be honest, the evidence here is mostly theoretical. The clearest signal comes from a different drug (carbamazepine), and lab results on diosmin and CYP3A4 are actually mixed. So this may not amount to much in real life. Still, since darolutamide is an important cancer treatment, please check with your oncologist or pharmacist before adding diosmin so they can keep an eye on you.

Still have a question about this interaction?

Contact Dr. Brian directly

References 3 sources behind this record

  1. Bedada SK, Neerati P. Modulation of CYP3A enzyme activity by diosmin and its consequence on carbamazepine pharmacokinetics in rats. Naunyn Schmiedebergs Arch Pharmacol. 2018;391(2):115-21. PubMed
  2. Burkina V, Zlabek V, Halsne R, Ropstad E, Zamaratskaia G. In vitro effects of the citrus flavonoids diosmin, naringenin and naringin on the hepatic drug-metabolizing CYP3A enzyme in human, pig, mouse and fish. Biochem Pharmacol. 2016;110-111:109-16 PubMed
  3. Bedada SK, Boga PK. Influence of diosmin on the metabolism and disposition of carbamazepine in healthy subjects. Xenobiotica. 2017;47(10):879-84. PubMed
Moderate Interaction 2 of 2

Diosmin With P-glycoprotein Substrates

Darolutamide is also in our P-glycoprotein Substrates category.

Interaction Details Explained

Theoretically, diosmin might increase levels of drugs that are substrates of P-glycoprotein (P-gp).
Preliminary laboratory research suggests that diosmin inhibits P-gp. Additionally, pharmacokinetic research in healthy male subjects shows that taking diosmin (Venex) 500 mg daily for 10 days prior to oral administration of fexofenadine 120 mg increases blood levels of fexofenadine, a P-gp substrate, by approximately 49% and decreases the apparent oral clearance of fexofenadine by 41%. The time taken to reach maximum plasma concentration, the half-life, and the apparent renal clearance of fexofenadine are not affected. For this reason, it is speculated that diosmin inhibits P-gp in the intestine, but not in the kidney or liver.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on lab or animal research, not studies in people.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Diosmin + P-glycoprotein Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the gist for your situation. Darolutamide (Nubeqa) is moved around by a transporter called P-glycoprotein, which acts like a gatekeeper in your gut that limits how much of the drug gets absorbed. Lab research hints that diosmin can block that gatekeeper, so in theory a bit more darolutamide could slip into your bloodstream. Higher levels could mean a greater chance of side effects like fatigue, rash, or pain in your arms and legs.

I want to be honest about the strength of this: it comes from test-tube and human studies using other drugs, not darolutamide itself, so it's mostly theoretical. Please don't stop or change anything on your own. Just run the diosmin past your oncology pharmacist or doctor first so they can give you the all-clear.

Still have a question about this interaction?

Contact Dr. Brian directly

References 2 sources behind this record

  1. Yoo HH, Lee M, Chung HJ, Lee SK, Kim DH. Effects of diosmin, a flavonoid glycoside in citrus fruits, on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 cells. J Agric Food Chem. 2007 Sep 5;55(18):7620-5. PubMed
  2. Bedada SK, Boga PK, Kotakonda HK. The effect of diosmin on the pharmacokinetics of fexofenadine in healthy human volunteers. Xenobiotica. 2017;47(3):230-35. PubMed
Know someone taking this combination? Share

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Diosmin Also Interacts With Other Medications

Besides Darolutamide, Diosmin has 884 moderate known drug interactions in our database. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Diosmin

Covers the 2,830 medications we’ve checked against Diosmin. Pick one to open its full report.

Everything Else You Take

See Every Supplement That Interacts With Darolutamide

Take other supplements too? 149 supplements have a documented interaction with Darolutamide, each explained on its page.

By severity: 3 major, 106 moderate and 40 minor.

The Most Serious There Right Now:

Open the Darolutamide interaction pageEvery supplement checked against Darolutamide, ranked by severity
One More Smart Check

Taking Diosmin as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Diosmin. We have broken down 121 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against Darolutamide:

Get to Know Each One

About Diosmin and Darolutamide

Supplement

About Diosmin

Diosmin is a citrus-derived flavonoid most often used for vein-related problems such as chronic venous insufficiency and hemorrhoids, and it is usually combined with a related flavonoid called hesperidin. Some studies suggest it may help relieve leg swelling and hemorrhoid symptoms, but quality varies. Talk to your pharmacist or doctor before starting it, especially if you are pregnant or breastfeeding.

Full Diosmin guide: uses, dosage, safety and every interaction
Medication

About Darolutamide

Brand name: Nubeqa

Nubeqa (darolutamide) is approved to treat two forms of advanced prostate cancer in adults. The first is non-metastatic castration-resistant prostate cancer (nmCRPC) — prostate cancer that keeps growing despite hormone-lowering treatment and has not yet spread to other parts of the body. The second is metastatic castration-sensitive prostate cancer (mCSPC) — prostate cancer that has spread but still responds to hormone-lowering therapy.

Darolutamide: uses, dosage and side effects Darolutamide: interactions with other drugs Taking more than these two? Check Diosmin and Darolutamide with everything else you take Darolutamide NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Similar Pairs

More Pairs Like Diosmin and Darolutamide

Other drugs in the category this interaction applies to, and other supplements people check with Darolutamide.

Moderate

Also in Our Cytochrome P450 3A4 (CYP3A4) Substrates Category

Diosmin interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

383 more in this category are on the Diosmin interactions list.

Moderate

Also in Our P-glycoprotein Substrates Category

Diosmin interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

185 more in this category are on the Diosmin interactions list.

Other Supplements With Darolutamide

The most serious documented interactions with Darolutamide first, then supplements with none on record, the most looked-up leading.

Show all 27 supplementsShow fewer
Keep Checking

Other Drugs & Diosmin

Browse every other medication we’ve checked against Diosmin — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
884Moderate
0Minor
1,945No known interaction
Moderate

Moderate: 884 interactions

Showing 60 of 884 moderate interactions — see all 884 on the Diosmin page.

No Interaction 1,945 drugs checked — show the list
How Much People Look This Up

Where Diosmin and Darolutamide Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Diosmin
Top 25%

#168 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Darolutamide
Top 25%

#547 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Diosmin and Darolutamide Together: Common Questions

Can you take Diosmin with Darolutamide?
There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Read the full details on this page and confirm with your pharmacist before combining them.
Can you take Diosmin with Nubeqa?
Nubeqa is a brand name of darolutamide, so the answer is the same as for darolutamide. There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Everything on this page applies to Nubeqa too.
Why are there 2 interaction records for Diosmin and Darolutamide?
We file interactions under single medicines and under categories of medicines that share an effect. Darolutamide is named in, or belongs to, 2 of the categories we list for Diosmin, so 2 records apply. They can describe the same effect, so they are not 2 separate risks. We list every one so nothing is missed, and the most serious one sets the overall rating.
How serious is the Diosmin and Darolutamide interaction?
We rate it Moderate. This combination may require monitoring, a dose adjustment, or separating the times you take each one. Consult your pharmacist before using them together.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Sources

Sources & How We Checked

Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.

Content is reviewed by the HelloPharmacist Editorial Team, the pharmacists on our staff and those we contract. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep Exploring
Rating Key

What Our Interaction Ratings Mean

Every interaction on this page is rated three ways: how serious it is, how likely it is to happen, and how strong the research behind it is.

See what each rating means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Likelihood: How Likely Is It to Happen?

How strong the proof is that the interaction really happens in people. More filled steps, stronger proof.

  • LikelyShown in well-controlled studies in people.
  • ProbableShown in small studies in people, or in animal studies backed by case reports.
  • PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
  • UnlikelySeen in lab or animal research, but shown not to happen in people.

Evidence: How Strong Is the Research?

The quality of the studies behind the rating, graded from A, the strongest, to D.

  • Grade AStrong: well-run randomized trials in people, or a review that pooled several of them.
  • Grade BFair: smaller or less rigorous trials in people, or studies that followed or compared groups of people.
  • Grade CLimited: the agreement or opinion of experts, not studies.
  • Grade DWeak: reports of single cases, lab or animal research, or what is expected from how the two work.

Still Have a Question About Diosmin and Darolutamide?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.